Mr Tremmel has almost 30 years of leadership experience as an executive at Medtronic, where he oversaw the successful design, development and commercial launch of a number of new medical and neuromodulation devices.
Over the course of his career at Medtronic, Mr Tremmel served in a variety of senior management positions, including president of the neurological division, president of the physio control division, president of the tachyarrhythmia management division and president of the interventional vascular division. Mr Tremmel currently serves as a board member for a number of corporate and civic organizations.
Mark Knudson, president and CEO of EnteroMedics, said: “We are very pleased to have Jon join the EnteroMedics board of directors. His previous leadership roles in the medical device industry are extensive and Jon’s highly relevant neuromodulation domain experience will be a great addition to the board of our company. We look forward to his contribution to the development and commercialization of vagal blocking therapy.”